LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Liabilities from Discontinued Operations (2016 - 2021)

LivaNova's (LIVN) quarterly Liabilities from Discontinued Operations came in at $27.1 million in Q1 2021, down 8.63% quarter-over-quarter from $29.7 million in Q4 2020.

Analysis

LivaNova (LIVN) Liabilities from Discontinued Operations (2016 - 2021) Analysis & Trends

LivaNova has disclosed Liabilities from Discontinued Operations across 5 years of filings, most recently posting $27.1 million for Q1 2021.

  • In Q1 2021, Liabilities from Discontinued Operations changed N/A year-over-year to $27.1 million; the TTM figure through Mar 2021 stood at $27.1 million (changed N/A YoY), while the FY2020 annual figure was $29.7 million, changed N/A from the prior year.
  • Liabilities from Discontinued Operations came in at $27.1 million for Q1 2021 at LivaNova, down from $29.7 million in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of $85.0 million in Q1 2018 to a low of $27.1 million in Q1 2021.
  • Average Liabilities from Discontinued Operations over 4 years is $55.0 million, with a median of $53.9 million recorded in 2017.
  • The largest YoY upside for Liabilities from Discontinued Operations was 6.21% in 2017 against a maximum downside of 6.21% in 2017.
  • Over 4 years, Liabilities from Discontinued Operations stood at $78.1 million in 2017, then advanced by 8.86% to $85.0 million in 2018, then plunged by 65.08% to $29.7 million in 2020, then declined by 8.63% to $27.1 million in 2021.
  • Per Business Quant data, the three most recent Liabilities from Discontinued Operations figures were $27.1 million in Q1 2021, $29.7 million in Q4 2020, and $85.0 million in Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 27.12 Mn
Dec 31, 2020 29.68 Mn
Mar 31, 2018 84.99 Mn
Dec 31, 2017 78.08 Mn
Dec 31, 2016 83.24 Mn